U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misbranded Drugs For Sale To U.S. Consumers
U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misbranded Drugs For Sale To U.S. Consumers
美国食品药品监督管理局给Ozempen.com发送了警告信; FDA发现其将未经批准和标签错误的Semaglutide药品引入州际商业; 要求停止向美国消费者销售任何未经批准和标签错误的药品。
U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misbranded Drugs For Sale To U.S. Consumers
美国食品药品监督管理局给Ozempen.com发送了警告信; FDA发现其将未经批准和标签错误的Semaglutide药品引入州际商业; 要求停止向美国消费者销售任何未经批准和标签错误的药品。